Figure 4 From: The protein C pathway: implications for the design of the RESPOND study Effect of DrotAA infusion on protein C levels in PROWESS [9]. Shown are percentage changes in protein C level from baseline until day 7; the data are the observed data with no imputation. DrotAA, drotrecogin alfa (activated); PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.Back to article page